Physician profile
Michael Mikita
NPI 1902454804
$1,626.30
in general payments reported to CMS, 2019-2025
22 companies · $536 in 2025
The $536 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $349 · 2023: $504 · 2024: $238 · 2025: $536.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,209 · Education: $68.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,209.17 |
| Education | $68.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sumitomo Pharma America, INC. | $315.22 | 2023-2025 | Gemtesa, Orgovyx |
| Abbvie INC. | $253.79 | 2022-2025 | |
| Astellas Pharma US INC | $202.16 | 2022-2025 | Xtandi |
| Myriad Genetic Laboratories, INC. | $182.46 | 2023-2024 | Prolaris |
| Janssen Biotech, INC. | $109.06 | 2022-2025 | Erleada |
| Teleflex LLC | $78.81 | 2022-2024 | Urolift |
| Urogen Pharma, INC. | $62.47 | 2025 | |
| Medtronic, INC. | $51.49 | 2025 | Altaviva |
| Urovant Sciences INC | $44.14 | 2022 | |
| Axonics, INC. | $41.94 | 2022-2023 | Bulkamid |
| Accord Healthcare, INC. | $37.34 | 2023-2024 | |
| Merck Sharp & Dohme LLC | $32.96 | 2022-2024 | Keytruda, Welireg |
| Avyxa Pharma, LLC | $29.71 | 2025 | |
| Procept Biorobotics Corporation | $28.92 | 2024 | Aquabeam System |
| Boston Scientific Corporation | $28.40 | 2023 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| 180 Medical, INC. | $25.50 | 2023 | Gentlecath Glide |
| Abc Home Medical Supply, INC. | $20.79 | 2025 | |
| Olympus America INC. | $19.10 | 2025 | Itind System |
| Sun Pharmaceutical Industries INC. | $18.73 | 2022 | |
| Novartis Pharmaceuticals Corporation | $15.81 | 2022 | |
| Genzyme Corporation | $14.70 | 2022 | |
| Myovant Sciences INC. | $12.80 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Mikita listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.